Nike's China Wipeout and the Cost-Cutting Gamble Wall Street Won't Yet Buy

Nike shares dropped 3.6% to EUR 30.10 after a Q1 revenue miss and weak full-year guidance; the stock is down 42% year to date.

Nike shares closed Friday at EUR 30.10, down 3.6% on the session, after the sportswear giant served up a first-quarter revenue miss and a full-year outlook that gave investors little to cheer. The retreat pushed the stock's year-to-date decline to 42%, a slump that has turned the company's turnaround plan from a background narrative into the main event.

The numbers behind the drop were laid out in filings with the U.S. Securities and Exchange Commission. Revenue for the core Nike brand slipped 4% to $11.2 billion in the first quarter of fiscal 2027, falling short of the $11.32 billion analysts had penciled in. Greater China was the sharpest wound: sales there tumbled 26% on a currency-neutral basis, with EMEA also finishing lower. The direct-to-consumer engine sputtered too, as NIKE Direct revenue fell 9% and digital sales dropped 13%.

A Forecast That Offered No Quick Fix

Management's guidance did nothing to steady nerves. Nike expects revenue to decline at a high single-digit percentage rate for the full fiscal year, and projects adjusted diluted earnings per share of $1.15 to $1.35 — a range that excludes roughly $0.15 per share in restructuring charges tied to the company's overhaul.

The scope of that overhaul, known internally as Pace, is substantial. Nike is targeting about $2.5 billion in cumulative savings by fiscal 2031, funded by pre-tax charges of approximately $1.0 billion over the same stretch, most of them employee-related and tied to a leaner organizational structure. Roughly $0.3 billion of those charges are expected to land in fiscal 2027 alone.

Two Camps, One Stock

Analysts spent Friday recalibrating. Morgan Stanley's Alex Straton trimmed her price target to $27 from $31 while keeping an Underweight rating. UBS cut its 12-month target to $34 from $42, maintaining a Neutral stance. Baird moved to $36 from $44, also Neutral. Guggenheim stood apart, lowering its target to $50 from $60 but holding on to a Buy recommendation.

That split captures the debate now shaping Nike's valuation. The bull case rests on early signs of operational resilience: gross margin expanded 60 basis points to 42.8% in the quarter, diluted EPS came in at $0.48, and growth in the North American home market partly offset declines elsewhere. If Pace delivers cost relief faster than planned and margins hold, the argument goes, Nike could bottom out sooner than the broader market fears.

Skeptics see deeper problems that belt-tightening alone cannot fix. Soft consumer spending in key international markets, intensifying competition, and the structural damage in China and digital weigh on the brand's earning power. Market watchers cited by media outlets pointed to business issues that cost cuts are unlikely to resolve in short order.

The Line in the Sand at EUR 27.91

For traders, the technical picture matters as much as the fundamentals. Nike's 52-week low of EUR 27.91 now serves as the key support level. Holding above it keeps alive the prospect of a gradual stabilization; a sustained break below could invite a deeper correction as the market prices in a more severe earnings hit.

The next real checkpoint arrives with detailed second-quarter results, when investors will learn whether the first Pace charges are already being offset by tangible savings. Until then, the question hanging over the stock is simple: can Nike bank the cost benefits quickly enough to stop the revenue bleed from hollowing out the brand's profitability?